共 50 条
Human regulatory T cells induce T-lymphocyte senescence
被引:144
|作者:
Ye, Jian
[2
]
Huang, Xingxu
[3
]
Hsueh, Eddy C.
[4
]
Zhang, Qunyuan
[5
]
Ma, Chunling
[2
,6
]
Zhang, Yanping
[4
]
Varvares, Mark A.
[7
]
Hoft, Daniel F.
[2
]
Peng, Guangyong
[1
,2
]
机构:
[1] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, Doisy Res Ctr, St Louis, MO 63104 USA
[2] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA
[3] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China
[4] St Louis Univ, Sch Med, Dept Surg, St Louis, MO 63104 USA
[5] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA
[6] Shandong Med Coll, Dept Immunol & Microbiol, Linyi, Peoples R China
[7] St Louis Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, St Louis, MO 63104 USA
来源:
基金:
美国国家卫生研究院;
关键词:
MEDIATED SUPPRESSION;
TOLL-LIKE;
TRIGGERS SENESCENCE;
CELLULAR SENESCENCE;
CD4(+) CD25(+);
CANCER;
PATHWAY;
MECHANISMS;
EFFECTOR;
IMMUNOTHERAPY;
D O I:
10.1182/blood-2012-03-416040
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Regulatory T (Treg) cells have broad suppressive activity on host immunity, but the fate and function of suppressed responder T cells remains largely unknown. In the present study, we report that human Treg cells can induce senescence in responder naive and effector T cells in vitro and in vivo. Senescent responder T cells induced by human Treg cells changed their phenotypes and cytokine profiles and had potent suppressive function. Furthermore, Treg-mediated molecular control of senescence in responder T cells was associated with selective modulation of p38 and ERK1/2 signaling and cell-cycle-regulatory molecules p16, p21, and p53. We further revealed that human Treg-induced senescence and suppressor function could be blocked by TLR8 signaling and/or by specific ERK1/2 and p38 inhibition in vitro and in vivo in animal models. The results of the present study identify a novel mechanism of human Treg cell suppression that induces targeted responder T-cell senescence and provide new insights relevant for the development of strategies capable of preventing and/or reversing Treg-induced immune suppression. (Blood. 2012; 120(10):2021-2031)
引用
收藏
页码:2021 / 2031
页数:11
相关论文